MC1R

MC1R
Name	Melanocortin 1 receptor
Organism	Homo sapiens
Uniprot	P22888
Location	Chromosome 16
Function	G protein-coupled receptor regulating melanogenesis

MC1R MC1R encodes a G protein-coupled receptor that regulates pigmentary, inflammatory, and cellular stress responses in vertebrates and is a focal point in studies spanning Charles Darwin-era natural history to modern molecular genetics. The receptor integrates signals from peptide ligands and intracellular effectors to bias melanocyte output toward eumelanin or pheomelanin, linking molecular signaling to visible phenotypes that have attracted attention from researchers at institutions such as Harvard University, University of Oxford, Max Planck Society, CNRS, and National Institutes of Health.

Function and Signaling

MC1R is activated by endogenous melanocortin peptides such as alpha-melanocyte-stimulating hormone (α-MSH) and adrenocorticotropic hormone (ACTH), which are produced by cells in pathways studied at Columbia University, Yale University, Stanford University, University of Cambridge, and Massachusetts General Hospital. Upon ligand binding MC1R couples primarily to the Gs heterotrimeric G protein, stimulating adenylate cyclase and raising cyclic AMP levels; downstream effectors include protein kinase A and cyclic AMP response element-binding protein, processes investigated at Salk Institute, Roche, Novartis, Pfizer, and GlaxoSmithKline. MC1R also engages beta-arrestin-mediated scaffolding and can signal through MAP kinase cascades; investigators at National Cancer Institute, Imperial College London, Weill Cornell Medicine, Johns Hopkins University, and Vanderbilt University have explored these alternative pathways. The signaling outcome modulates melanin synthesis in melanocytes and influences oxidative stress responses relevant to studies at European Molecular Biology Laboratory, Cold Spring Harbor Laboratory, Karolinska Institutet, and University of Tokyo.

Structure and Genetics

MC1R is a seven-transmembrane domain receptor encoded by a single exon located on human chromosome 16q24.3; its molecular architecture has been characterized using mutagenesis and comparative modeling efforts at University of California, San Francisco, ETH Zurich, Dana-Farber Cancer Institute, Moffitt Cancer Center, and University of Pennsylvania. The coding region typically yields a ~317 amino acid protein, with critical residues in transmembrane helices and intracellular loops mediating G protein interaction—features examined in structural biology labs at Max Planck Institute for Biophysical Chemistry, Riken, Cold Spring Harbor Laboratory, and European Synchrotron Radiation Facility. Population genetics studies map MC1R variation across global cohorts collected by consortia including 1000 Genomes Project, HapMap Project, Human Genome Diversity Project, UK Biobank, and International HapMap Consortium, while clinical sequencing efforts by Mayo Clinic, Cleveland Clinic, and Memorial Sloan Kettering have cataloged pathogenic and functional alleles.

Variants and Phenotypic Effects

Numerous nonsynonymous MC1R variants associate with red hair, fair skin, freckling, and altered tanning response; classic alleles such as R151C, R160W, and D294H have been characterized in cohorts from Scotland, Ireland, Iceland, Finland, and Norway by researchers at University College Dublin, Trinity College Dublin, University of Edinburgh, University of Helsinki, and University of Iceland. Other variants influence pigmentation in Mediterranean, East Asian, and African populations documented in studies at University of Barcelona, Seoul National University, Peking University, University of Cape Town, and University of São Paulo. Functional assays performed at University of Michigan, University of Toronto, University of Sydney, Monash University, and University of Auckland reveal loss-of-function, partial loss, and dominant-negative effects that shift melanin synthesis toward pheomelanin, impacting photoprotection and visible traits cataloged by naturalists such as Gregor Mendel and later geneticists including Thomas Hunt Morgan.

Evolution and Population Genetics

MC1R exhibits contrasting patterns of constraint and diversity: strong purifying selection in many non-European populations and relaxed constraint or positive selection in portions of northern and western European populations—a theme explored in comparative genomics by teams at Princeton University, University of Chicago, University of California, Berkeley, Stanford University School of Medicine, and Broad Institute. Studies comparing humans with mammals such as Mus musculus, Canis lupus familiaris, Felis catus, Bos taurus, and Gallus gallus reveal convergent evolution of coat and plumage coloration implicating MC1R and parallel loci; evolutionary questions have been addressed by researchers at Duke University, University of Washington, University of California, Davis, University of Edinburgh Roslin Institute, and Natural History Museum, London. Ancient DNA projects undertaken by Max Planck Institute for Evolutionary Anthropology and University of Copenhagen have traced allele frequency shifts in prehistoric populations.

Clinical Significance and Disease Associations

MC1R variants modulate skin cancer risk, particularly cutaneous melanoma and non-melanoma skin cancers; epidemiologic links have been evaluated by multicenter networks including European Organisation for Research and Treatment of Cancer, American Association for Cancer Research, International Agency for Research on Cancer, World Health Organization, and Cancer Research UK. Beyond oncogenic risk, MC1R genotype influences analgesia, immune responses, and outcomes in inflammatory conditions, with translational research at Mayo Clinic, Johns Hopkins Hospital, University Hospitals Cleveland Medical Center, Karolinska University Hospital, and Hôpital Européen Georges-Pompidou. Pharmacogenomic implications are being explored for targeted therapies and cosmetic interventions in clinical trials registered by U.S. Food and Drug Administration-linked investigators and industry partners such as AstraZeneca.

Research Tools and Experimental Studies

Experimental toolkits for MC1R include receptor-specific antibodies, ligand analogs, reporter assays, transgenic and knockout mouse models generated at Jackson Laboratory, EMBL-EBI, and Sanger Institute, and CRISPR-engineered cell lines from Addgene-linked labs. High-throughput screening, single-cell transcriptomics, and imaging performed at Wellcome Sanger Institute, Broad Institute of MIT and Harvard, European Bioinformatics Institute, Center for Genomic Regulation, and Howard Hughes Medical Institute laboratories continue to refine MC1R biology. Ongoing multidisciplinary collaborations among clinical centers, academic labs, and biopharmaceutical companies aim to translate mechanistic insights into interventions for pigmentary disorders and skin cancer prevention.

Category:Human proteins